48 related articles for article (PubMed ID: 35520857)
21. Targeting of the mitochondrion by dinuclear thiolato-bridged arene ruthenium complexes in cancer cells and in the apicomplexan parasite Neospora caninum.
Basto AP; Anghel N; Rubbiani R; Müller J; Stibal D; Giannini F; Süss-Fink G; Balmer V; Gasser G; Furrer J; Hemphill A
Metallomics; 2019 Feb; 11(2):462-474. PubMed ID: 30620038
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the Activities of Dinuclear Thiolato-Bridged Arene Ruthenium Complexes against Toxoplasma gondii.
Basto AP; Müller J; Rubbiani R; Stibal D; Giannini F; Süss-Fink G; Balmer V; Hemphill A; Gasser G; Furrer J
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652238
[TBL] [Abstract][Full Text] [Related]
23. In-vitro and in-vivo evaluation of the anticancer activity of diruthenium-2, a new trithiolato arene ruthenium complex [(η6-p-MeC6H4Pri)2Ru2(μ-S-p-C6H4OH)3]Cl.
Muthná D; Tomšík P; Havelek R; Köhlerová R; Kasilingam V; Čermáková E; Stíbal D; Řezáčová M; Süss-Fink G
Anticancer Drugs; 2016 Aug; 27(7):643-50. PubMed ID: 27187018
[TBL] [Abstract][Full Text] [Related]
24. Interactions of the "piano-stool" [ruthenium(II)(η(6) -arene)(quinolone)Cl](+) complexes with water; DFT computational study.
Zábojníková T; Cajzl R; Kljun J; Chval Z; Turel I; Burda JV
J Comput Chem; 2016 Jul; 37(19):1766-80. PubMed ID: 27185047
[TBL] [Abstract][Full Text] [Related]
25. Chlorambucil conjugates of dinuclear p-cymene ruthenium trithiolato complexes: synthesis, characterization and cytotoxicity study in vitro and in vivo.
Stíbal D; Therrien B; Süss-Fink G; Nowak-Sliwinska P; Dyson PJ; Čermáková E; Řezáčová M; Tomšík P
J Biol Inorg Chem; 2016 Jul; 21(4):443-52. PubMed ID: 27040952
[TBL] [Abstract][Full Text] [Related]
26. Structural analysis of ruthenium-arene complexes using ion mobility mass spectrometry, collision-induced dissociation, and DFT.
Czerwinska I; Far J; Kune C; Larriba-Andaluz C; Delaude L; De Pauw E
Dalton Trans; 2016 Apr; 45(15):6361-70. PubMed ID: 26880308
[TBL] [Abstract][Full Text] [Related]
27. Biological studies of chalcogenolato-bridged dinuclear half-sandwich complexes.
Johnpeter JP; Gupta G; Kumar JM; Srinivas G; Nagesh N; Therrien B
Inorg Chem; 2013 Dec; 52(23):13663-73. PubMed ID: 24245963
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes.
Gupta G; Garci A; Murray BS; Dyson PJ; Fabre G; Trouillas P; Giannini F; Furrer J; Süss-Fink G; Therrien B
Dalton Trans; 2013 Nov; 42(43):15457-63. PubMed ID: 24022745
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, characterisation and in vitro anticancer activity of hexanuclear thiolato-bridged arene ruthenium metalla-prisms.
Furrer MA; Garci A; Denoyelle-Di-Muro E; Trouillas P; Giannini F; Furrer J; Clavel CM; Dyson PJ; Süss-Fink G; Therrien B
Chemistry; 2013 Feb; 19(9):3198-203. PubMed ID: 23344898
[TBL] [Abstract][Full Text] [Related]
30. Insights into the mechanism of action and cellular targets of ruthenium complexes from NMR spectroscopy.
Giannini F; Paul LE; Furrer J
Chimia (Aarau); 2012; 66(10):775-80. PubMed ID: 23146264
[TBL] [Abstract][Full Text] [Related]
31. Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(η6-p-MeC6H4Pri)2Ru2(SC6H4-p-X)3]+: synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential.
Giannini F; Furrer J; Ibao AF; Süss-Fink G; Therrien B; Zava O; Baquie M; Dyson PJ; Stěpnička P
J Biol Inorg Chem; 2012 Aug; 17(6):951-60. PubMed ID: 22707191
[TBL] [Abstract][Full Text] [Related]
32. Revised self-consistent continuum solvation in electronic-structure calculations.
Andreussi O; Dabo I; Marzari N
J Chem Phys; 2012 Feb; 136(6):064102. PubMed ID: 22360164
[TBL] [Abstract][Full Text] [Related]
33. Efficient oxidation of cysteine and glutathione catalyzed by a dinuclear areneruthenium trithiolato anticancer complex.
Giannini F; Süss-Fink G; Furrer J
Inorg Chem; 2011 Nov; 50(21):10552-4. PubMed ID: 21981265
[TBL] [Abstract][Full Text] [Related]
34. Effect of the damping function in dispersion corrected density functional theory.
Grimme S; Ehrlich S; Goerigk L
J Comput Chem; 2011 May; 32(7):1456-65. PubMed ID: 21370243
[TBL] [Abstract][Full Text] [Related]
35. Organometallic anticancer compounds.
Gasser G; Ott I; Metzler-Nolte N
J Med Chem; 2011 Jan; 54(1):3-25. PubMed ID: 21077686
[No Abstract] [Full Text] [Related]
36. Thiophenolato-bridged dinuclear arene ruthenium complexes: a new family of highly cytotoxic anticancer agents.
Gras M; Therrien B; Süss-Fink G; Zava O; Dyson PJ
Dalton Trans; 2010 Nov; 39(42):10305-13. PubMed ID: 20890536
[TBL] [Abstract][Full Text] [Related]
37. Arene ruthenium complexes as anticancer agents.
Süss-Fink G
Dalton Trans; 2010 Feb; 39(7):1673-88. PubMed ID: 20449402
[TBL] [Abstract][Full Text] [Related]
38. A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu.
Grimme S; Antony J; Ehrlich S; Krieg H
J Chem Phys; 2010 Apr; 132(15):154104. PubMed ID: 20423165
[TBL] [Abstract][Full Text] [Related]
39. Insertion reactions of CS2, COS, and PhNCS at thiolate-bridged diiron centers.
Chen Y; Peng Y; Chen P; Zhao J; Liu L; Li Y; Chen S; Qu J
Dalton Trans; 2010 Mar; 39(12):3020-5. PubMed ID: 20221535
[TBL] [Abstract][Full Text] [Related]
40. Ruthenium-based chemotherapeutics: are they ready for prime time?
Antonarakis ES; Emadi A
Cancer Chemother Pharmacol; 2010 May; 66(1):1-9. PubMed ID: 20213076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
